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Background
Long non-coding RNAs (lncRNAs) are molecules that
have been recently described to participate in tumor
progression, however, they remain poorly characterized
and their role in brain cancers, such as medulloblastoma
(MDL) has not been studied in detail as yet. This study
aimed to assess the gene expression profile of a lncRNA
named EVF-2 in MDL tissue samples and cell lines.
Materials and methods
We used two human MDL tissue samples, three human
MDL cell lines (UW473, UW472 and DAOY), three
human cerebellum tissue samples and two human cere-
bellum primary culture. The cell lines were characterized
morphologically by light microscopy and immunopheno-
typically by flow cytometry. MDL cell lines and tissue
samples, as well as, control cerebellum primary culture
and tissue were evaluated for gene expression profile of
the EVF-2 lncRNA gene by Quantitative Real Time PCR.
Results
MDLcell lines are morphologically presented as polygonal
and fibroblastoid cells. Immunophenotypically, MDL cell
lines showed a high percentage (70-99%) for CD44, CD73,
CD105, CD166 and CD29 and a low or absence (0-4.2%)
for CD144, CD31, CD34 and CD45. MDL cell lines were
different for CD271 (3,26-26,9%), CD24 (20-64%), CD146
(34-90%), CD90 (3,7-99%), CD140b (0,3-6%), and were
positive for the cancer stem cell marker CD133 (2,9-5,3%).
The EVF-2 lncRNA showed 81 ± 13 times more expressed
in MDL tissue samples when compared to cerebellum tis-
sue and 119 ± 48, 476 ± 74, 227 ± 33 times more expressed
in MDL cell lines UW402, UW473 and DAOY respec-
tively, when compared to cerebellum primary culture.
Conclusion
These data demonstrate that MDL cell lines present a
immunophenotype somewhat different for some markers
and that EVF-2 lncRNA is more expressed in both
human MDL cell lines and tumor tissue when compared
to cerebellum primary culture and tissue, respectively.
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